Patents by Inventor Annina Roeytenberg

Annina Roeytenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions for treatment of patients with neurodegeneration following ischemic insult
    Patent number: 9351927
    Abstract: Pharmaceutical compositions for treating and/or pre-treating or preconditioning the animal central nervous system against the effects of Alzheimer's Disease including the associated neurodegeneration and cognitive, behavioral and physical impairments. In one embodiment, an effective dose of deferoxamine (DFO) is administered to the upper one-third of the subject patient's nasal cavity to effectively bypass the blood-brain barrier, thereby allowing application of the DFO dose directly to the central nervous system.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: May 31, 2016
    Assignee: HealthPartners Researh Foundation
    Inventors: William H. Frey, II, Samuel Scott Panter, Leah Ranae Bresin Hanson, Annina Roeytenberg
  • METHODS AND PHARMACEUTICAL COMPOSITIONS FOR DIFFERENTIALLY ALTERING GENE EXPRESSION TO PROVIDE NEUROPROTECTION FOR THE ANIMAL CENTRAL NERVOUS SYSTEM AGAINST THE EFFECTS OF ISCHEMIA, NEURODEGENERATION, TRAUMA AND METAL POISONING
    Publication number: 20100267834
    Abstract: Pharmaceutical compositions for treating and/or pre-treating or preconditioning the animal central nervous system against the effects of Alzheimer's Disease including the associated neurodegeneration and cognitive, behavioral and physical impairments. In one embodiment, an effective dose of deferoxamine (DFO) is administered to the upper one-third of the subject patient's nasal cavity to effectively bypass the blood-brain barrier, thereby allowing application of the DFO dose directly to the central nervous system.
    Type: Application
    Filed: July 2, 2010
    Publication date: October 21, 2010
    Applicant: HealthPartners Research Foundation
    Inventors: William H. Frey, II, Samuel Scott Panter, Leah Ranae Bresin Hanson, Annina Roeytenberg
  • Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity
    Patent number: 7776312
    Abstract: Methods and pharmaceutical compositions for preconditioning and/or providing neuroprotection to the animal central nervous system against the effects of neurological disorders involving ischemia, trauma, metal poisoning and neurodegeneration, including the associated cognitive, behavioral and physical impairments. In one embodiment, the method is accomplished by stimulating and/or stabilizing hypoxia-inducible factor-1? (HIF-1?). HIF-1? is known to provide a neuroprotective benefit under ischemic conditions. In another embodiment, the method is accomplished by differentially reducing, inhibiting or preventing the increased expression of selected genes caused by neurological disorders. Patients at risk for certain diseases or disorders that are associated with risk for cerebral ischemia may benefit, e.g., those at risk for Alzheimer's disease, Parkinson's disease, Wilson's disease, Huntington's disease, thalassemia or stroke, or those patients having head or spinal cord injury.
    Type: Grant
    Filed: October 13, 2006
    Date of Patent: August 17, 2010
    Assignee: HealthPartners Research Foundation
    Inventors: William H. Frey, II, Samuel Scott Panter, Leah Ranae Bresin Hanson, Annina Roeytenberg